Growth Metrics

Eli Lilly (LLY) Construction in Progress (2016 - 2024)

Eli Lilly filings provide 13 years of Construction in Progress readings, the most recent being $8.2 billion for Q4 2024.

  • On a quarterly basis, Construction in Progress rose 62.17% to $8.2 billion in Q4 2024 year-over-year; TTM through Dec 2024 was $8.2 billion, a 62.17% increase, with the full-year FY2024 number at $8.2 billion, up 62.17% from a year prior.
  • Construction in Progress hit $8.2 billion in Q4 2024 for Eli Lilly, up from $5.1 billion in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $8.2 billion in Q4 2024 to a low of $2.1 billion in Q4 2020.
  • Median Construction in Progress over the past 5 years was $2.8 billion (2022), compared with a mean of $4.1 billion.
  • Biggest five-year swings in Construction in Progress: increased 1.82% in 2021 and later surged 81.67% in 2023.
  • Eli Lilly's Construction in Progress stood at $2.1 billion in 2020, then grew by 1.82% to $2.2 billion in 2021, then grew by 28.51% to $2.8 billion in 2022, then soared by 81.67% to $5.1 billion in 2023, then surged by 62.17% to $8.2 billion in 2024.
  • The last three reported values for Construction in Progress were $8.2 billion (Q4 2024), $5.1 billion (Q4 2023), and $2.8 billion (Q4 2022) per Business Quant data.